Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation

Winnie W Pong1, Samantha B Higer, Scott M Gianino

  • 1Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA.

Annals of Neurology
|February 21, 2013
PubMed

Insights

Stromal microglia, crucial for tumor growth, express CX3CR1. Reducing this receptor in neurofibromatosis type 1 (NF1)-associated optic gliomas delays tumor formation, suggesting new stroma-directed therapies.

Area of Science:

  • Oncology
  • Neuroscience
  • Immunology

Background:

  • Traditional cancer models focus on neoplastic cells.
  • Emerging evidence highlights the role of non-neoplastic stromal cells in tumor progression.
  • Stromal cells, including microglia, significantly influence tumor microenvironment and growth.

Purpose of the Study:

  • To investigate the role of stromal microglia and CX3CR1 in neurofibromatosis type 1 (NF1)-associated optic glioma.
  • To determine if targeting CX3CR1 can impact optic glioma development and growth.

Main Methods:

  • Utilized a genetically engineered mouse model of NF1-associated optic glioma.
  • Assessed CX3CR1 chemokine receptor expression in stromal microglia.
  • Genetically reduced Cx3cr1 expression in Nf1 optic glioma mice to evaluate its effect on tumor formation.

Main Results:

  • Stromal microglia in NF1 optic gliomas express the CX3CR1 receptor.
  • Reduced CX3CR1 expression led to decreased optic nerve microglia.
  • Genetic reduction of Cx3cr1 expression significantly delayed optic glioma formation in Nf1 mice.

Conclusions:

  • Stromal microglia play a critical role in the initiation and progression of NF1-associated optic gliomas.
  • CX3CR1 signaling in microglia is a key factor in optic glioma development.
  • These findings support the development of stroma-directed therapies targeting microglia for pediatric gliomas.

Related Concept Videos